Pharmacodynamic effect of switching therapy in patients with high on-treatment platelet reactivity and genotype variation with high clopidogrel Dose versus prasugrel: the RESET GENE trial. [electronic resource]
Producer: 20130402Description: 698-704 p. digitalISSN:- 1941-7632
- Aged
- Area Under Curve
- Aryl Hydrocarbon Hydroxylases -- genetics
- Blood Platelets -- drug effects
- Chi-Square Distribution
- Clopidogrel
- Coronary Artery Disease -- blood
- Cross-Over Studies
- Cytochrome P-450 CYP2C19
- Drug Substitution
- Female
- Genotype
- Humans
- Male
- Middle Aged
- Myocardial Ischemia -- blood
- Percutaneous Coronary Intervention -- adverse effects
- Phenotype
- Piperazines -- administration & dosage
- Platelet Aggregation Inhibitors -- administration & dosage
- Platelet Function Tests
- Prasugrel Hydrochloride
- Prospective Studies
- Purinergic P2Y Receptor Antagonists -- administration & dosage
- Receptors, Purinergic P2Y12 -- blood
- Rome
- Thiophenes -- administration & dosage
- Ticlopidine -- administration & dosage
- Treatment Outcome
No physical items for this record
Publication Type: Comparative Study; Journal Article; Randomized Controlled Trial
There are no comments on this title.
Log in to your account to post a comment.